S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MNMD Mind Medicine MindMed Inc

6.96

0.26 (3.88%)

01 Jan 2025 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

12/26/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Daniel Rollings Karlin

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Mind Medicine MindMed Charts.

Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Mind Medicine MindMed Charts.

Mind Medicine MindMed Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 28 December 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 28 December 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 28 December 2024 (5 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 27 December 2024 (6 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 27 December 2024 (6 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 27 December 2024 (6 days ago) • Edgar (US Regulatory)

MindMed to Be Added to the Nasdaq Biotechnology Index
Thursday 19 December 2024 (2 weeks ago) • Business Wire

Form 8-K - Current report
Monday 16 December 2024 (2 weeks ago) • Edgar (US Regulatory)

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)
Monday 16 December 2024 (2 weeks ago) • Business Wire

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
Wednesday 11 December 2024 (3 weeks ago) • Business Wire

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)
Thursday 5 December 2024 (4 weeks ago) • Business Wire

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy
Tuesday 3 December 2024 (4 weeks ago) • Business Wire

More Mind Medicine MindMed Inc News Articles

Ssga Spdr Etfs Europe I ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions